(Q33878517)

29 July 2017

1 reference

title

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery (English)

1 reference

29 July 2017

3

Babiuk LA

1 reference

29 July 2017

Babiuk S

1

1 reference

29 July 2017

Baca-Estrada M

series ordinal

2

1 reference

29 July 2017

Ewen C

series ordinal

4

1 reference

29 July 2017

Foldvari M

series ordinal

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Journal of Controlled Release

29 July 2017

1 reference

29 July 2017

66

1 reference

29 July 2017

2-3

1 reference

29 July 2017

199-214

1 reference

Live attenuated bacterial vaccines: new approaches for safety and efficacy.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Genetically engineered vaccines: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Development of porcine adenovirus-3 as an expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Adenovirus vectors as potential vaccines against herpes simplex virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

DNA vaccines against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Structure, function, and differentiation of the keratinocyte

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Structure and function of basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Keratins and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Desmosomes, corneosomes and desquamation. An ultrastructural study of adult pig epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Epidermal lipids, barrier function, and desquamation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Biological features of genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

B.C.G. Vaccination by jet injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Trials of intradermal hepatitis B vaccines in Gambian children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Gene transfer into mammalian cells by jet injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Depth-targeted efficient gene delivery and expression in the skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

A mechanistic study of ultrasonically-enhanced transdermal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Ultrasound-mediated transdermal protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Photomechanical transcutaneous delivery of macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Novel polymer-grafted starch microparticles for mucosal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Oral administration of polymer-grafted starch microparticles activates gut-associated lymphocytes and primes mice for a subsequent systemic antigen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Oral vaccination of animals with antigens encapsulated in alginate microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Controlled gene delivery by DNA-gelatin nanospheres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Gene transfer by DNA-gelatin nanospheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Taking polycation gene delivery systems from in vitro to in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Peptide-mediated gene delivery: influence of peptide structure on gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

A new non-viral DNA delivery vector: the terplex system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Amphotericin B in liposomes: a novel therapy for histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Surrogate cells or Trojan horses. The discovery of liposomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

DNA-lipid complexes: stability of honeycomb-like and spaghetti-like structures

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Liposome-skin interactions and their effects on the skin permeation of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Interaction of liposomes with human skin in vitro--the influence of lipid composition and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Cationic lipids destabilize lysosomal membrane in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Parameters influencing the introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Mucosal immunization with DNA-liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Liposome-mediated DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Neutralizing antiviral B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Polyvalent recombinant antigens: a new vaccine strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Hybrid Ty virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

In vitro gene transfer using human papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Enhancing immune responses using suicidal DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Palmitoyl derivatives of interferon alpha: potential for cutaneous delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Percutaneous absorption after twenty-five years: or "old wine in new wineskins"

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Percutaneous transport in relation to stratum corneum structure and lipid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Product-delivering liposomes specifically target hair follicles in histocultured intact skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

The feasibility of targeted selective gene therapy of the hair follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Liposome-medicated gene transfer and expression via the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Topical gene delivery to murine skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Vaccination onto bare skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

Immunization via hair follicles by topical application of naked DNA to normal skin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2899%2900274-6

7 January 2021

10.1016/S0168-3659(99)00274-6

Identifiers

DOI

1 reference

29 July 2017

1 reference